Kenvue concludes media pitch for APAC market

Kenvue, the consumer arm previously part of Johnson & Johnson, has concluded its APAC media pitch appointing Publicis Media as its media agency. The pitch which was called earlier in 2024, saw the account move from IPG to Publicis Media. MARKETING-INTERACTIVE also understands that R3 was handling the pitch. 

MARKETING-INTERACTIVE has reached out for a statement.

Earlier this year, Kenvue added FCB and BBDO on to its creative agency roster.

Recently, Kenvue announced its financial results for the fiscal third quarter where CEO Thibaut Mongon said during the third quarter, the company continued to drive strong productivity and realise efficiency benefits from “Our Vue Forward” in which it is reinvesting behind its iconic brands to unleash the full potential of the business and fulfil its commitment to create long-term shareholder value.

Don’t miss: Kenvue promotes Venaig Solinhac to VP global brand lead, baby

Kenvue is one of the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, its iconic brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol.

“This reinvestment is enabling us to continue to drive share gains in Self Care, deliver broad-based growth across the Essential Health categories, and build the right foundation in Skin Health and Beauty, where we are seeing early signs of recovery. As we continue to advance our new Kenvue playbook, our team is making strong progress toward transforming into a leaner, more efficient and agile consumer health organisation driving sustainable and profitable growth,” he said.

The Kenvue name was first announced in September 2022 by J&J, and it was said Kenvue (pronounced ken-view), is inspired by two powerful ideas: “ken” – meaning knowledge, an English word primarily used in Scotland, and “vue,” referencing sight. With rich knowledge of human needs and deep consumer insights, Kenvue will deliver meaningful, personal health solutions, explained J&J. Kenvue’s purpose will guide the company’s actions and long-term aspirations, from strategy to talent philosophy, said the firm.

The move to become independent comes after J&J announced in late 2021 its intent to separate the Company’s Consumer Health business, creating a new publicly traded company. The planned separation would create two global leaders that are better positioned to deliver improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth, the company had then said.

Related articles:
Johnson & Johnson names new Vision Care marketing lead for 4 regions
J&J's new consumer health biz Kenvue files to become independent firm
Venaig Solinhac joins Johnson & Johnson Consumer Health